Salix (SLXP) options active on elevated volatility elevated into FDA meeting
Tweet Send to a Friend
Salix Pharmaceutical (Nasdaq: SLXP) is recently down $1.42 to $24.16. FDA; SLXP's drug rifaximin (liver ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
